Africa Medical Cannabis Market Report by Species (Cannabis Indica, Sativa, Hybrid), Derivative (Cannabidiol, Tetrahydrocannabinol, and Others), Route of Administration (Capsules and Oral Solutions, Vaporizers, Smoking, Topicals, and Others), Application (Cancer, HIV/AIDS, Epilepsy, Pain, and Others) End User (Pharmaceutical Industry, Research and Development Centers, and Others), and Country 2024-2032

Africa Medical Cannabis Market Report by Species (Cannabis Indica, Sativa, Hybrid), Derivative (Cannabidiol, Tetrahydrocannabinol, and Others), Route of Administration (Capsules and Oral Solutions, Vaporizers, Smoking, Topicals, and Others), Application (Cancer, HIV/AIDS, Epilepsy, Pain, and Others) End User (Pharmaceutical Industry, Research and Development Centers, and Others), and Country 2024-2032

Report Format: PDF+Excel | Report ID: SR112025A3213

Market Overview:

The Africa medical cannabis market size is expected to exhibit a growth rate (CAGR) of 19.2% during 2024-2032.

Report Attribute 
Key Statistics
Base Year
2023
Forecast Years
2024-2032
Historical Years
2018-2023
Market Growth Rate 2024-2032 19.2%


Medical cannabis refers to cannabinoid drugs that are extracted from the Cannabis Sativa plant. These drugs are primarily bifurcated into tetrahydrocannabinol (THC) and cannabidiol (CBD). Medical cannabis includes both psychoactive and non-psychoactive ingredients that are precisely used for medicinal purposes. These ingredients help in treating insomnia, inflammation, depression, anxiety, chronic pain, etc. In Africa, the increasing legalization of medical cannabis have led to the faster approvals of THC- and CBD-infused drugs, thereby driving the market growth.

The growing awareness towards several health benefits of medical cannabis for cancer patients in treating poor appetite and weight loss, reducing pain and muscle spasms, and relieving nausea, is augmenting the market in Africa. Furthermore, the increasing popularity of cannabis-infused edible products, such as pills, chocolates, brownies, cookies, etc., for prolonged treatment of psychotic ailments, is also propelling the product demand. Additionally, due to the presence of low-cost labor resources and favorable geographical conditions, many international players are investing in Africa for producing medical cannabis, which will further continue to drive the market growth. 

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the Africa medical cannabis market report, along with forecasts at the regional and country levels from 2024-2032. Our report has categorized the market based on species, derivative, route of administration, application and end user.

Breakup by Species:

  • Cannabis Indica
  • Sativa
  • Hybrid
     

Breakup by Derivative:

  • Cannabidiol
  • Tetrahydrocannabinol
  • Others
     

Breakup by Route of Administration:

  • Capsules and Oral Solutions
  • Vaporizers
  • Smoking
  • Topicals
  • Others
     

Breakup by Application:

  • Cancer
  • HIV/AIDS
  • Epilepsy
  • Pain
  • Others
     

Breakup by End User:

  • Pharmaceutical Industry
  • Research and Development Centers
  • Others
     

Breakup by Country:

  • Lesotho
  • Zimbabwe
  • South Africa
  • Ghana
  • Zambia
  • Malawi
     

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being AgriPharma Pty LTD., Bophelo Bioscience & Wellness (Pty) Ltd. (Halo Labs Inc), Canopy Growth Corporation, Medigrow Africa, Medi Kingdom, MG Health, Pharmaceutical Development Company, Precision Extraction Solutions and Verve Dynamics (Pty) Ltd.

Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Million
Segment Coverage Species, Derivative, Route of Administration, Application, End User, Country
Countries Covered Lesotho, Zimbabwe, South Africa, Ghana, Zambia, Malawi
Companies Covered AgriPharma Pty LTD., Bophelo Bioscience & Wellness (Pty) Ltd. (Halo Labs Inc), Canopy Growth Corporation, Medigrow Africa, Medi Kingdom, MG Health, Pharmaceutical Development Company, Precision Extraction Solutions and Verve Dynamics (Pty) Ltd.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3699
Five User License: US$ 4699
Corporate License: US$ 5699
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report:

  • How has the Africa medical cannabis market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Africa medical cannabis market?
  • What are the key regional markets?
  • What is the breakup of the market based on the species?
  • What is the breakup of the market based on the derivative?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the Africa medical cannabis market and who are the key players?
  • What is the degree of competition in the industry?

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Africa Medical Cannabis Market Report by Species (Cannabis Indica, Sativa, Hybrid), Derivative (Cannabidiol, Tetrahydrocannabinol, and Others), Route of Administration (Capsules and Oral Solutions, Vaporizers, Smoking, Topicals, and Others), Application (Cancer, HIV/AIDS, Epilepsy, Pain, and Others) End User (Pharmaceutical Industry, Research and Development Centers, and Others), and Country 2024-2032
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials